Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 17/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12219398 | 0.87 | CFTR (0.59) | CFTRNPC1RAB9AKMT2AGAA | |
| SCHEMBL1014057 | 0.87 | CFTR (0.57) | CFTR | |
| SCHEMBL12219093 | 0.86 | CFTR (0.65) | CFTRNPC1RAB9AKMT2AGAA | |
| SCHEMBL1014783 | 0.84 | CFTR (0.53) | CFTRNPC1RAB9A | |
| SCHEMBL12188939 | 0.84 | CFTR (0.60) | CFTR | |
| SCHEMBL12188916 | 0.84 | CFTR (0.58) | CFTR | |
| SCHEMBL12218340 | 0.83 | CFTR (0.57) | CFTRNPC1RAB9AKMT2AGAA | |
| SCHEMBL12217318 | 0.83 | CFTR (0.56) | CFTRNPC1RAB9AKMT2AGAA | |
| SCHEMBL12218605 | 0.83 | CFTR (0.56) | CFTRNPC1RAB9AKMT2AGAA | |
| SCHEMBL12217385 | 0.82 | CFTR (0.55) | CFTRNPC1RAB9AKMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102245573-B | Heteroaryl derivatives as cftr modulators | VERTEX PHARMA | 2013-11-20 | — | — | CN | disclosed |
| CN-103382201-A | Heteroaryl derivatives as cftr modulators | VERTEX PHARMA | 2013-11-06 | — | — | CN | disclosed |
| CN-102245573-A | Heteroaryl derivatives as cftr modulators | VERTEX PHARMA | 2011-11-16 | — | — | CN | disclosed |